The company, which operates 179 cancer treatment centers across the U.S. and Latin America, blamed the bankruptcy on costs associated with litigation, legal settlements and complying with electronic records regulations, as well as declining revenue per treatment, according to Reuters.
The cancer care provider paid nearly $55 million to settle false claims allegations last year, and it is also being investigated in regards to a 2015 data breach.
Interim CEO Paul Rundell told Reuters 21st Century Oncology will lower its debt by $500 million through the bankruptcy process.
More articles on healthcare finance:
Trump’s $4.1 trillion budget: 9 healthcare takeaways
CMS further delays major bundled payment initiatives: 4 things to know
Austin hospital closes after 133 years; relocates services
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
